4.5 Article

Toll-like receptor 3-elicited MAPK activation induces stabilization of interferon-β mRNA

Journal

CYTOKINE
Volume 57, Issue 3, Pages 337-346

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.cyto.2011.11.024

Keywords

AU-rich elements; IFN-beta; mRNA stability; p38 MAPK; Toll-like receptor 3

Funding

  1. Liaison Committee between the Central Norway Regional Health Authority (RHA)
  2. Norwegian University of Science and Technology (NTNU)
  3. National Programme for Research in Functional Genomics in Norway (FUGE)
  4. Research Council of Norway, the Faculty of Medicine, NTNU
  5. St. Olavs Hospital

Ask authors/readers for more resources

Prolonged release of cytokines after activation of the innate immune system may lead to systemic infection and inflammatory diseases. Many cytokines with short half-lives contain adenine- and uridine-rich elements (AREs) in their 3'-untranslated region (UTR), which mediate mRNA destabilization. The Toll-like receptors (TLRs) TLR3 and TLR4 induce immune responses via the adaptor proteins TRIF or TRIF and MyD88, respectively, leading to IFN-beta production. The 3'-UTR of IFN-beta mRNA contains an ARE sequence. We demonstrate that the TLR3 ligand dsRNA and the TLR4 ligand LPS induce stabilization of IFN-beta mRNA transcripts in monocyte-derived dendritic cells. In cells from TRIF-/- and MyD88(-/-) mice we found that dsRNA-induced stabilization of IFN-beta mRNA is TRIF-dependent. MAPK-activated protein 2 (MK2) has previously been found to regulate mRNA stabilization. We show that dsRNA elicits increased MK2 activation, mediated by TRIF and p38 MAPK. Chemical inhibition of p38 and MK2, and siRNA knockdown of MK2 relieved dsRNA-triggered prolongation of IFN-beta mRNA half-life. Taken together, these results suggest that TLR3 induces signaling mechanisms involving TRIF, p38 MAPK and MK2 to enhance stabilization of IFN-beta mRNA contributing to enhanced IFN-beta levels during pathogen infections. (C) 2011 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available